Achieve Positive Treatment Outcomes That Lead to Negative Test Results
Positive cases of coronavirus are trending in the right direction, but there is still work to do. For those administering treatment, having clearly labeled drug containers — and a paper trail to match — is critical to success.
REGEN-COV™, an investigational therapy that uses Casirivimab and Imdevimab together, has been given Emergency Use Authorization by the FDA. Kits containing the antibody cocktail should be labeled as such, along with patient charts for accurate record keeping. Our label inventory is stocked with these specific drug labels — and hundreds of others — to clearly identify containers and prevent administration errors.
Achieve positive outcomes that lead to negative results. Order now for same-day shipping and keep the trend going!
